For 2020, 29 EU/EEA Member States reported 14 428 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases (14 137) corresponds to a crude rate of 4.2 cases per 100 000 population.
This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 27 March-2 April 2022, and includes updates on COVID-19, the influx of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, seasonal influenza, Crimean-Congo haemorrhagic fever, and poliomyelitis.
For 2019, 30 EU/EEA Member States reported 29 996 cases of hepatitis B virus (HBV) infection. Excluding the five countries that only reported acute cases, the number of cases, 29 518, corresponds to a crude rate of 7.4 cases per 100 000 population.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25 April - 1 May 2021 and includes updates on Crimean-Congo haemorrhagic fever, COVID-19, Ebola virus disease and dengue.